JUBILANT PHARMOVA LTD (JUBLPHARMA)

NSE: ₹970.70
BSE: ₹969.75
Stock Performance
Corporate Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report

2026-05-27 20:32:59
Earnings Call Transcript

Earnings Call Transcript

2026-05-27 20:24:53
2026-05-23 14:45:56
Tax Demand Order Received By Company's Step Down Subsidiary

Tax Demand order received by company's step down subsidiary

2026-05-22 19:42:36
2026-05-22 14:52:44
2026-05-22 14:41:22

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 1,586.90 1,680.30 1,677.10 175.86 1,731.70 1,752.30 1,821.70 1,928.80 1,900.70 1,966.40 2,122.50 2,290.00
YOY Revenue Growth % 10.17% 5.05% 8.03% -89.52% 9.12% 4.28% 8.62% 996.78% 9.76% 12.22% 16.51% 18.73%
Other Income 8.60 9.90 35.80 1.44 14.00 21.70 9.20 11.90 12.00 9.80 20.50 23.70
Total Income 1,595.50 1,690.20 1,712.90 177.30 1,745.70 1,774.00 1,830.90 1,940.70 1,912.70 1,976.20 2,143.00 2,313.70
Total Expenses + 1,568.90 1,601.20 1,625.00 166.12 1,641.90 1,615.30 1,681.20 1,731.30 1,758.20 1,780.00 2,009.80 2,124.00
Cost of Materials Consumed 428.10 464.40 431.50 49.73 465.30 469.00 467.00 584.00 520.50 564.90 592.10 642.80
Employee Benefit Expense 547.70 531.80 581.50 55.50 552.90 564.30 560.10 590.60 591.10 636.20 706.40 766.90
Other Expenses 349.50 349.40 341.70 40.48 365.60 343.80 399.80 366.70 401.80 392.30 410.30 470.50
Operating Profit 18.00 79.10 52.10 9.74 89.80 137.00 140.50 197.50 142.50 186.40 112.70 166.00
OPM % 1.1% 4.7% 3.1% 5.5% 5.2% 7.8% 7.7% 10.2% 7.5% 9.5% 5.3% 7.2%
Profit Before Tax + 26.60 89.00 87.90 -5.71 499.70 144.50 130.80 206.10 154.50 190.40 93.50 176.00
Tax Expense 20.60 26.90 21.50 0.47 17.90 42.00 30.10 54.80 52.00 70.50 37.70 56.70
Tax % 77.4% 30.2% 24.5% - 3.6% 29.1% 23% 26.6% 33.7% 37% 40.3% 32.2%
Profit After Tax 6.00 62.10 66.40 -6.18 481.80 102.50 100.70 151.30 102.50 119.90 55.80 119.30
EPS (Basic) 0.40 3.94 4.22 -3.69 30.44 6.47 6.37 9.71 6.49 7.59 3.52 7.55

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 8,279.60 7,234.50 670.29 6,281.73 6,059.17 6,098.54
YOY Revenue Growth % 14.45% 979.31% -89.33% 3.67% -0.65% -
Other Income 66.00 56.80 6.87 38.33 82.28 17.64
Total Income 8,345.60 7,291.30 677.16 6,320.06 6,141.45 6,116.18
Total Expenses + 7,672.00 6,669.70 645.63 6,247.71 5,501.02 5,235.12
Cost of Materials Consumed 2,320.30 1,985.30 182.13 1,666.41 1,348.70 1,348.75
Employee Benefit Expense 2,700.60 2,267.90 221.60 2,166.02 2,043.39 1,922.88
Other Expenses 1,674.90 1,475.90 144.54 1,461.53 1,442.44 1,243.18
Operating Profit 607.60 564.80 24.66 34.02 558.15 863.42
OPM % 7.3% 7.8% 3.7% 0.5% 9.2% 14.2%
Profit Before Exceptional 673.60 621.60 31.53 72.35 640.43 881.06
Exceptional Items -59.20 359.50 -16.89 -56.82 0.00 -21.23
Profit Before Tax + 614.40 981.10 14.64 15.53 640.43 859.83
Tax Expense 216.90 144.80 7.37 80.41 227.41 24.22
Tax % 35.3% 14.8% 50.3% 517.8% 35.5% 2.8%
Profit After Tax 397.50 836.30 7.27 -64.88 413.02 835.61
EPS (Basic) 25.15 52.99 4.87 -3.83 26.00 52.48

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 11,413.40 9,179.20 767.24 7,394.25 6,481.68 5,965.61
Property, Plant & Equipment 3,509.60 2,132.30 215.78 2,297.53 2,201.26 2,007.92
Capital Work in Progress 2,961.50 2,714.70 125.23 773.25 291.83 277.78
Non-Current Investments 60.60 36.00 3.44 32.79 43.49 240.96
Goodwill 2,826.10 2,541.00 246.39 2,428.59 2,242.75 2,129.96
Other Intangible Assets 197.70 181.40 19.25 457.14 128.58 470.86
Current Assets + 4,109.30 3,509.70 363.22 3,762.40 3,509.19 2,952.50
Inventories 1,231.50 1,129.20 128.96 1,380.53 1,254.87 1,129.38
Trade Receivables 1,069.60 891.50 91.59 961.24 927.99 819.90
Cash and Cash Equivalents 1,267.10 1,088.30 95.64 1,013.92 983.82 501.96
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 7,095.60 6,238.60 542.11 5,391.79 5,316.40 4,741.52
Equity Share Capital 15.80 15.80 1.58 15.91 15.92 15.92
Other Equity 7,077.00 6,239.10 541.81 5,383.37 5,302.64 4,725.57
Non-Current Liabilities 5,888.20 4,353.20 423.84 3,992.46 3,082.87 3,127.76
Current Liabilities 2,538.90 2,164.60 188.90 1,772.40 1,591.60 1,048.83
Total Liabilities 8,427.10 6,517.80 612.74 5,764.86 4,674.47 4,176.59

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 1,226.80 1,072.10 97.13 660.67 837.54 1,482.37
Cash from Investing Activities -1,260.00 487.70 -60.79 -544.41 -380.37 720.83
Cash from Financing Activities 94.90 -1,452.70 -43.25 -156.69 -32.60 3,453.29
Net Increase/Decrease in Cash 178.80 131.90 -5.75 30.10 481.86 5,656.49